The present invention discloses a pharmaceutical antiretroviral composition comprising at least one or more anti-retroviral agents and to the manufacturing process thereof. Disclosed herein further is the use of said composition for the prevention, treatment or prophylaxis of diseases caused by retroviruses, especially acquired immune deficiency syndrome or an HIV infection.
